Should I Buy Teva Pharmaceutical Industries Ltd Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. TEVA has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
TEVA stock price ended at $16.96 on Friday, after rising0.12%
The Teva Pharmaceutical Industries Ltd stock price increased by 0.12% on the last trading day (23 May 2025), rising from 16.57 to 16.96. Throughout the last trading session, the stock experienced a fluctuation of 3.20% , ranging from a day low of $16.55 to a day high of 17.08. The price has declined in 5 of the last 10 days, resulting in a total change of 0.18% during this period. On the last day, trading volume decrease by -1.21M shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 6.48M shares were traded, amounting to approximately 109.30M.
TEVA Technical Signals
TEVA(Teva Pharmaceutical Industries Ltd Corp) has 4 buy signals and 0 sell signals now. The current trend is consolidation starting from 2025-05-08. The total price change during this trend is -6.14%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of TEVA over the last 5 trading days is 140.10M. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
TEVA Moving Average Analysis
Teva Pharmaceutical Industries Ltd's overall moving average trend leans more bullish as of Saturday, May 24, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $18.205996666666664, and $18.849666666666664. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $16.123336666666667, and $15.479666666666667. A break-down below any of these levels will issue sell signals.
TEVA Short Selling Analysis
The short sale ratio of Teva Pharmaceutical Industries Ltd(TEVA) as of 16 May 2025 is 24.46%, rising from last trading day. With increasing price from 16.87 to 16.94. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Sell
0
Buy
4
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
1.343
Bullish
Momentum (10 days)
MOM_10 > 0
0.03
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.462
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
10.78
Bullish
0 Bearish Signals
0 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
No Data
TEVA Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Teva Pharmaceutical Industries Ltd(TEVA), our algorithm predicts TEVA's 1-month price at $26.81, with an 58.26%upwardshift. Using a similarity score up to 98.35%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Teva Pharmaceutical Industries Ltd (TEVA.N) stock, as of Sunday, May 18, 2025 , forecasts a 58.26% change over the next month, based on its high correlation with XXII.O stock patterns. The similarity between their price movements over the analyzed periods is 98.35%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
TEVA
No Data
XXII
Up: 58.26%Similarity: 98.35%
Name
Similarity
Up/Down
XXII.O
98.35%
+58.26%
EBR.B.N
97.96%
+6.50%
ACR.N
97.93%
-0.10%
FENC.O
97.91%
-18.44%
SCOR.O
97.91%
+7.30%
DECK.N
97.89%
-9.73%
AZZ.N
97.88%
-2.04%
CIB.N
97.81%
-13.63%
HII.N
97.81%
-4.08%
FPH.N
97.80%
-5.64%
TEVA Seasonality Analysis
Based on TEVA's historical stock price data across all years, the probability of a positive return in May is45.45%, suggesting it maynotbe an ideal month to invest in TEVA. In contrast,Januaryoffers the highest probability of positive returns at63.64%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Teva Pharmaceutical Industries Ltd (TEVA.N) stock in January has the highest probability of a positive return (63.64%), while August has the lowest probability (20.00%).
Performance Seasonality
The chart shows Teva Pharmaceutical Industries Ltd. (TEVA)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Teva Pharmaceutical Industries Ltd (TEVA.N) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. TEVA has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Teva Pharmaceutical Industries Ltd (TEVA.N) stock in a year?
The radar chart shows that buying Teva Pharmaceutical Industries Ltd (TEVA.N) stock in January has the highest probability of a positive return (63.64%), while August has the lowest probability (20.00%).
How has Teva Pharmaceutical Industries Ltd. (TEVA)'s stock price performed over the past three years?
TEVA's stock price rose by 9.55% in 2023,increased by 106.56% in 2024, and went down by 20.38% in 2025.
Is TEVA a buy based on overall technical signals summary?
TEVA has 4 buy signals and 0 sell signals now. Overall the technical rating for TEVA is Strong buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of TEVA.
What is the trend of Teva Pharmaceutical Industries Ltd (TEVA)'s moving average?
Teva Pharmaceutical Industries Ltd's overall moving average trend leans more bullish as of May 24 2025, with 1 negative signals and 3 positive signal.
What is price prediction for TEVA stock next month?
The price prediction chart for Teva Pharmaceutical Industries Ltd (TEVA.N) stock, as of May 18 2025, forecasts a 58.26% change over the next month, based on its high correlation with XXII stock patterns. The similarity between their price movements over the analyzed periods is 98.35%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for TEVA Stock?
### **Price Prediction for TEVA Stock in 2025**
Based on current trends and analysis, TEVA stock is expected to reach **$22 to $28** by the end of 2025.
**Reasons for the Prediction:**
1. **Analyst Consensus**: B of A Securities recently raised its price target for TEVA to $22, reflecting confidence in the company's growth prospects.
2. **Strong Earnings and Guidance**: TEVA reported strong Q1 2025 earnings, beating estimates, and raised its full-year guidance, signaling improved profitability.
3. **Product Growth**: The company's branded drugs, such as Austedo, are driving revenue growth, while the generics business is stabilizing.
4. **Cost-Cutting Measures**: TEVA's $700 million cost-saving initiative is expected to enhance margins and support long-term growth.
This prediction aligns with the company's "Pivot to Growth" strategy and improving financial health.
{RATING:symbol=TEVA, type=0}
What is price prediction 2030 for TEVA Stock?
Teva Pharmaceutical Industries (TEVA) is expected to reach a stock price of **$35 by 2030**, driven by its strong branded product growth, stabilization of generics business, and successful debt reduction efforts. The company's "Pivot to Growth" strategy and cost-cutting initiatives position it well for long-term profitability. Analysts have set a near-term price target of **$23**, reflecting confidence in its current trajectory.